You have full text access to this OnlineOpen article
trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets
Article first published online: 29 JAN 2009
DOI: 10.1038/sj.bjp.0702749
1999 British Pharmacological Society
Additional Information
How to Cite
Dobrydneva, Y., Williams, R. L. and Blackmore, P. F. (1999), trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. British Journal of Pharmacology, 128: 149–157. doi: 10.1038/sj.bjp.0702749
Publication History
- Issue published online: 29 JAN 2009
- Article first published online: 29 JAN 2009
- (Received May 10, 1999, Revised May 28, 1999, Accepted June 1, 1999)
References
- , & (1993). Plasma concentrations of phytoestrogens in Japanese men. Lancet, 342, 1209.
- , , , , , , & (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592–5595.
- (1997). Elementary and global aspects of calcium signalling. J. Physiol., 499.2, 291–306.
- , , , , , & (1995). Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tiss. React., 17, 1–3.
- & (1987). Rat platelet arachidonate metabolism in the presence of Ca2+, Sr2+ and Ba2+: studies using intact platelets and semi-purified phospholipase A2. Biochim. Biophys. Acta, 921, 541–551.
- , & (1987). Platelet aggregation and endogenous 5-HT secretion in presence of Ca2+, Sr2+ and Ba2+. Effect of calcium antagonists. Thromb. Res., 46, 779–791.
- , , & (1990). Progesterone and 17 α-hydroxyprogesterone: Novel stimulators of calcium influx in human sperm. J. Biol. Chem., 265, 1376–1380.
- , , , , & (1993). In Mechanisms of Platelet Activation and Control. (eds). Authi et al., pp. 17–36. Plenum Press: New York.
- & (1996). Pharmacological and functional properties of voltage-independent Ca2+ channels. Cell Calc., 19, 269–279.
- & (1994). In Haemostasis and Thrombosis. (eds). Bloom, A.L., Forbes, C.D., Thomas, D.P. & Tuddenham, E.G.D. pp. 89–114. London: Churchill Livingstone.
- , , , & (1998). Ca2+ pool emptying stimulates Ca2+ entry activated by S-nitrosylation. J. Biol. Chem., 273, 30855–30858.
- , , , , & (1998). Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett, 130, 143–152.
- , , & (1997). Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A., 94, 14138–14143.
- & (1994). Calcium signalling in platelets and other cells. Platelets, 5, 295–316.
- & (1994). Thrombopoiesis and platelet kinetics. In Haemostasis and Thrombosis. (eds). Bloom, A.L., Forbes, C.D., Thomas, D.P. & Tuddenham, E.G.D. pp. 31–47. London: Churchill Livingstone.
- & (1991). Pharmacological receptors on blood platelets. Pharmacol. Rev., 43, 243–298.
- , , , , , , , , , , & (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218–220.
- , , , , , , & (1993). Kinase inhibitors from Polygonum Cuspidatum. J. Nat. Prod., 56, 1805–1810.
- & (1998). Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr., 67, 867–872.
- (1995). Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med., 208, 44–50.
- & (1990). Thrombin stimulates the production of a novel polyphosphoinositide in human platelets. J. Biol. Chem., 265, 2441–2445.
- , & (1992). Evaluation of platelet calcium ion mobilization by the use of various divalent ions. Cell Calc., 13, 19–27.
- , , , & (1995). The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin. Chimica. Acta, 235, 207–219.
- , , , & (1996). Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chimica. Acta, 246, 163–182.
- & (1997). Store depletion and calcium influx. Physiol. Rev., 77, 901–930.
- , , , , , , & (1998). Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol., 123, 1691–1699.
- , & (1996). Arachidonate mobilization is coupled to depletion of intracellular calcium stores and influx of extracellular calcium in differentiated U937 cells. Biochim. Biophys. Acta, 1299, 342–352.
- , , , & (1999). Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid. J. Biol. Chem., 274, 175–182.
- (1997). Calcium entry mechanisms in human platelets. Exp. Physiol., 82, 807–823.
- & (1990). Calcium signaling in human platelets. Annu. Rev. Physiol., 52, 431–449.
- , , & (1992). Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calc., 13, 553–564.
- , & (1993a). The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets. FEBS Lett., 315, 242–246.
- , & (1993b). ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in Fura-2-loaded human platelets. J. Biol. Chem., 268, 18151–18156.
- , & (1997). Resveratrol: a molecule whose time has come? and gone Clin. Biochem., 30, 91–113.
- , & (1998). Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab., 83, 2223–2235.
- , , , & (1990). Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc. Natl. Acad. Sci. U.S.A, 87, 2466–2470.
- (1994). Platelet ultrastructure. In Haemostasis and Thrombosis. (eds). Bloom, A.L., Forbes, C.D., Thomas, D.P. & Tuddenham, E.G.D. pp. 49–87. London: Churchill Livingstone.
- & (1998). Recent phytoestrogen research. Chem. Industry, 1, 14–16.
- , , & (1988). Calcium channels in thrombin-activated human platelet membrane. Nature, 334, 703–705.

1476-5381/asset/olbannerleft.gif?v=1&s=198ba9e64c782a75183a18cb494f9d10ecc901ea)
1476-5381/asset/olbannerright.gif?v=1&s=0b2124237bd4227e7991f1ea05cd4bed2496a9ae)
1476-5381/asset/cover.gif?v=1&s=f56f5a76559ff1cebf2b6e329fe028f1e9e0f463)